Drug Profile
Research programme: amyotrophic lateral sclerosis vaccine - Amarna Therapeutics/Treeway
Alternative Names: Amyotrophic lateral sclerosis gene therapy vaccine - Amarna Therapeutics/Treeway; TW-003Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Treeway
- Developer Amarna Therapeutics; Treeway
- Class Gene therapies; Vaccines
- Mechanism of Action Gene transference; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Amyotrophic lateral sclerosis
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Amyotrophic-lateral-sclerosis in Netherlands (Parenteral)